Inspire Investing, LLC Immuno Gen, Inc. Transaction History

Inspire Investing, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$3.32 - $5.34 $298 - $480	-90 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$2.12 - $6.8 $190 - $612	90 New	90 $0
Q1 2018 Apr 13, 2018	SELL	$6.7 - $12.95 $1,326 - $2,564	-198 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$5.07 - $7.92 $1,003 - $1,568	198	198 $1,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.